Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Endometrial Neoplasms × Educational Status × Clear all

Phase

Status

Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Breast Neoplasms 3 Fallopian Tube Neoplasms 2 Stomach Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphedema 1 Lung Neoplasms 1 Gastritis, Atrophic 1 Endometrial Neoplasms 1 Depression 1 COVID-19 1 Brenner Tumor 1 Breast Carcinoma In Situ 1 Anxiety Disorders 1

Interventions

Paclitaxel 6 Radiotherapy 5 Carboplatin 5 olaparib 4 Cisplatin 4 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Metformin 3 lenvatinib 2 durvalumab 2 dostarlimab 2 anlotinib 2 Sentinel Lymph Node Biopsy 2 Reverse Transcriptase Polymerase Chain Reaction 2 Progesterone 2 Magnetic Resonance Spectroscopy 2 Hematologic Tests 2 Genetic Testing 2 Blood Specimen Collection 2 Amplified Fragment Length Polymorphism Analysis 2 vistusertib 1 serabelisib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 onapristone 1 niraparib 1 liposomal doxorubicin 1 ixabepilone 1 gallium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01853865 2017-11-06

OPAL

Odense University Hospital

Phase NA Unknown

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡